STRS Ohio’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $718K | Sell |
8,800
-12,600
| -59% | -$910K | ﹤0.01% | 930 |
|
|
2026
Q1 | $1.46M | Buy |
21,400
+800
| +4% | +$56.6K | 0.01% | 625 |
|
|
2025
Q4 | $1.56M | Sell |
20,600
-2,000
| -9% | -$145K | 0.01% | 609 |
|
|
2025
Q3 | $1.39M | Sell |
22,600
-1,200
| -5% | -$62.5K | 0.01% | 611 |
|
|
2025
Q2 | $1.16M | Buy |
23,800
+15,200
| +177% | +$722K | ﹤0.01% | 864 |
|
|
2025
Q1 | $438K | Hold |
8,600
| – | – | ﹤0.01% | 1261 |
|
|
2024
Q4 | $388K | Sell |
8,600
-12,600
| -59% | -$539K | ﹤0.01% | 1299 |
|
|
2024
Q3 | $787K | Buy |
21,200
+19,200
| +960% | +$643K | ﹤0.01% | 999 |
|
|
2024
Q2 | $61.2K | Buy |
+2,000
| New | +$64.8K | ﹤0.01% | 1774 |
|
|
2024
Q1 | – | Sell |
-2,200
| Closed | -$60K | – | 2015 |
|
|
2023
Q4 | $60K | Sell |
2,200
-500
| -19% | -$11.4K | ﹤0.01% | 1751 |
|
|
2023
Q3 | $60K | Sell |
2,700
-3,900
| -59% | -$145K | ﹤0.01% | 1775 |
|
|
2023
Q2 | $268K | Buy |
6,600
+2,200
| +50% | +$108K | ﹤0.01% | 1519 |
|
|
2023
Q1 | $213K | Buy |
4,400
+700
| +19% | +$32K | ﹤0.01% | 1586 |
|
|
2022
Q4 | $141K | Sell |
3,700
-21,200
| -85% | -$881K | ﹤0.01% | 1666 |
|
|
2022
Q3 | $1.25M | Buy |
24,900
+21,300
| +592% | +$1.04M | 0.01% | 767 |
|
|
2022
Q2 | $144K | Hold |
3,600
| – | – | ﹤0.01% | 1683 |
|
|
2022
Q1 | $134K | Hold |
3,600
| – | – | ﹤0.01% | 1793 |
|
|
2021
Q4 | $143K | Sell |
3,600
-5,100
| -59% | -$195K | ﹤0.01% | 1816 |
|
|
2021
Q3 | $323K | Sell |
8,700
-6,500
| -43% | -$267K | ﹤0.01% | 1645 |
|
|
2021
Q2 | $642K | Buy |
15,200
+300
| +2% | +$12.9K | ﹤0.01% | 1480 |
|
|
2021
Q1 | $705K | Sell |
14,900
-3,600
| -19% | -$214K | ﹤0.01% | 1419 |
|
|
2020
Q4 | $1.13M | Sell |
18,500
-4,000
| -18% | -$236K | ﹤0.01% | 980 |
|
|
2020
Q3 | $1.05M | Sell |
22,500
-1,800
| -7% | -$88.6K | ﹤0.01% | 904 |
|
|
2020
Q2 | $1.23M | Sell |
24,300
-1,000
| -4% | -$49.1K | 0.01% | 799 |
|
|
2020
Q1 | $1.13M | Sell |
25,300
-1,400
| -5% | -$70.5K | 0.01% | 682 |
|
|
2019
Q4 | $1.28M | Hold |
26,700
| – | – | 0.01% | 784 |
|
|
2019
Q3 | $902K | Buy |
26,700
+12,000
| +82% | +$522K | ﹤0.01% | 857 |
|
|
2019
Q2 | $661K | Buy |
14,700
+1,000
| +7% | +$39.5K | ﹤0.01% | 1066 |
|
|
2019
Q1 | $515K | Hold |
13,700
| – | – | ﹤0.01% | 1253 |
|
|
2018
Q4 | $470K | Buy |
13,700
+500
| +4% | +$18K | ﹤0.01% | 1282 |
|
|
2018
Q3 | $620K | Buy |
+13,200
| New | +$546K | ﹤0.01% | 1268 |
|
|
2015
Q3 | – | Sell |
-3,300
| Closed | -$141K | – | 1929 |
|
|
2015
Q2 | $158K | Buy |
+3,300
| New | +$193K | ﹤0.01% | 1611 |
|
|
2013
Q4 | – | Sell |
-4,400
| Closed | -$94K | – | 1802 |
|
|
2013
Q3 | $94K | Buy |
+4,400
| New | +$76.5K | ﹤0.01% | 1645 |
|
Other funds holding PTCT
RI
JT
STRS Ohio's PTCT Position: Q2 2026 in Review
STRS Ohio reduced its PTC Therapeutics (PTCT) stake by 59% in Q2 2026, selling an estimated $910K and leaving 8,800 shares worth $718K. The position accounts for ﹤0.01% of the portfolio, ranked #930.
STRS Ohio first reported a position in PTCT in Q3 2013 and has held it in 33 quarters since. The position peaked at $1.56M in Q4 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- STRS Ohio held 8,800 shares of PTC Therapeutics worth $718K as of Q2 2026.
- STRS Ohio sold 12,600 PTC Therapeutics shares in Q2 2026, an estimated $910K.
- PTC Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #930 holding.
- STRS Ohio first reported a position in PTC Therapeutics in Q3 2013 and has held it in 33 quarters since.
- STRS Ohio's PTC Therapeutics position peaked at $1.56M in Q4 2025.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.